Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
GLMD
#4055
Galmed Pharmaceuticals Ltd.
0.6
1
-7.58%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
Jahresspanne
Tagesänderung
-7.58%
Monatliche Änderung
-28.24%
6 month change
-56.74%
Jahresänderung
-72.27%
Vorheriger Schlusskurs
0.6
6
Open
0.6
1
Bid
Ask
Low
0.6
1
High
0.6
1
Volumen
2
Märkte
Aktien
Gesundheitswesen
GLMD
Open full chart
Financials
Overview
Finanzbericht
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
118.48 K
139.38 K
140.02 K
420.44 K
1.65 M
2.35 M
Valuation ratios
Enterprise value
—
—
—
—
577.63 K
—
Price to earnings ratio
—
—
—
—
0.39
—
Price to sales ratio
—
—
—
—
74.23
—
Price to cash flow ratio
—
—
—
—
0.5
—
Price to book ratio
—
—
—
—
0.18
—
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.55
0.89
1.08
0.42
0.41
-0.85
Return on equity %
0.65
1.06
1.33
0.5
0.46
-1.02
Return on invested capital %
402.77
-749.41
-3 585.75
-898.44
-517.57
—
Gross margin %
—
-477.9
100
100
100
—
Operating margin %
—
-132 K
-48.93 K
-17.15 K
-15.59 K
—
EBITDA margin %
—
-131.83 K
—
—
—
—
Net margin %
—
129.87 K
49.63 K
15.71 K
18.79 K
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
6.47
6.13
4.76
4.81
7.42
23.13
Inventory turnover
—
—
—
—
—
—
Asset turnover
0
0
0
0
0
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
0.03
0.03
0.05
0.05
0.16
Long term debt to total equity ratio
—
0.03
0.04
0.06
0.05
0.19
Per share metrics
Operating cash flow per share
—
240.7
132.45
26.59
6.32
-105.21
EBIT per share
—
-241.49
—
—
—
—
EBITDA per share
—
-241.18
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
—
254.54
98.8
45.06
12.78
411.18
Net current asset value per share
—
263.84
105.41
57.36
17.32
443.93
Tangible book value per share
—
223.17
96.1
60.14
17.54
396.94
Working capital per share
—
220.81
83.26
45.45
14.99
364.51
Book value per share
—
223.17
96.1
60.14
17.54
396.94
Nachrichten
Galmed Pharmaceuticals beruft außerordentliche Hauptversammlung für den 4. März ein/n
Galmed Pharmaceuticals schedules special shareholder meeting for March 4
Galmed Pharmaceuticals: Nasdaq-Notierung nach Kursverfall gefährdet
Galmed Pharmaceuticals receives Nasdaq minimum bid price notice
Galmed präsentiert Daten zum Potenzial von Aramchol bei Leberkrebs
Galmed to present data on Aramchol’s potential in liver cancer
Galmed-Aktie legt nach Patent für MASH-Kombinationstherapie zu
Galmed stock rises after patent grant for MASH combo therapy
Südkorea erteilt Galmed Patent für MASH-Kombinationstherapie
Galmed receives patent for combination therapy in South Korea
Optimistischer CEO-Brief treibt Galmed-Aktie an
Galmed Pharmaceuticals stock rises on CEO’s optimistic outlook